| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:461093325:1841 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:461093325:1841?format=raw |
LEADER: 01841cam a2200421 a 4500
001 3915409
005 20221027000931.0
008 850405s1984 enka b 101 0 eng d
010 $a 84045600
020 $a0126916608 (alk. paper)
035 $a(OCoLC)11234446
035 $a(OCoLC)ocm11234446
035 $a(CStRLIN)NYCM85-B1629
035 $9ADG7732HS
035 $a(NNC)3915409
035 $a3915409
040 $aDNLM/DLC$cDLC$dCStRLIN$dNNC-M
050 00 $aQP603.M6$bM65 1984
060 0 $aQV 77.5 M7504 1983
082 0 $a574.19/258$219
245 00 $aMonoamine oxidase and disease :$bprospects for therapy with reversible inhibitors /$cedited by K.F. Tipton, P. Dostert, and M. Strolin Benedetti.
260 $aLondon ;$aOrlando, Fla. :$bAcademic Press,$c1984.
300 $axxxiii, 694 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $a"Based on the proceedings of a conference held 26-28 October 1983 in Paris, France"--P. [ii].
500 $aOrganized by the Centre de recherche Delalande.
504 $aIncludes bibliographies and indexes.
650 0 $aMonoamine oxidase$vCongresses.
650 0 $aMonoamine oxidase$xInhibitors$xTherapeutic use$vCongresses.
650 2 $aMonoamine Oxidase.$0https://id.nlm.nih.gov/mesh/D008995
650 2 $aMonoamine Oxidase Inhibitors.$0https://id.nlm.nih.gov/mesh/D008996
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aTipton, Keith F.$0http://id.loc.gov/authorities/names/n78088965
700 1 $aDostert, P.$0http://id.loc.gov/authorities/names/n84102351
700 1 $aStrolin Benedetti, M.$0http://id.loc.gov/authorities/names/n84102353
710 2 $aCentre de recherche Delalande.$0http://id.loc.gov/authorities/names/n84198682
852 00 $boff,hsl$hQP603.M6$iM752 1984